SpringerLink
Log in

Atrial Natriuretic Peptide

An Overview of Clinical Pharmacology and Pharmacokinetics

  • Review Article
  • Drug Disposition
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

The atrial natriuretic peptide (ANP) is part of a new family of cardiac hormones regulating water and salt homeostasis. Besides acting as a blood pressure-lowering agent, it also exerts potent natriuretic and diuretic effects. ANP can be considered an endogenous antagonist of the renin-angiotensin-aldosterone system and the antidiuretic hormone. One of the roles of ANP is to protect the body against fluid overload: it decreases intravascular fluid volume, which in turn diminishes cardiac secretion of ANP. The pharmacokinetic parameters of ANP reported in the literature vary widely. In general, ANP rapidly disappears from plasma with a high total body clearance. This is in agreement with the short-lived effects of the hormone. The actions of ANP have led to efforts to use this peptide hormone in the treatment of various cardiovascular dis-orders such as hypertension and congestive heart failure. Intravenous ANP administration indeed resulted in beneficial effects in these disorders. However, the peptide nature of ANP and its rapid elimination from the circulation limit its suitability as a drug. More promising is the development of long-acting ANP analogues and inhibitors of ANP degradation. Proper understanding of ANP pharmacokinetics is essential for the clinical use of these pharmacological agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allen MJ, Ang VTY, Bennett ED, Jenkins JS. Atrial natriuretic peptide inhibits osmolality-induced arginine vasopressin release in man. Clinical Science 75: 35–39, 1988

    PubMed  CAS  Google Scholar 

  • Almeida FA, Suzuki M, Scarborough RM, Lewicki JA, Maack T. Clearance function of type C receptors of atrial natriuretic factor in rats. American Journal of Physiology 256: R469–R475, 1989

    PubMed  CAS  Google Scholar 

  • Anderson JV, Donckier J, McKenna WJ, Bloom SR. The plasma release of atrial natriuretic peptide in man. Clinical Science 71: 151–155, 1986

    PubMed  CAS  Google Scholar 

  • Anderson JV, Donckier J, Payne NN, Beacham J, Slater JD, et al. Atrial natriuretic peptide: evidence of action as a natriuretic hormone at physiological plasma concentrations in man. Clinical Science 72: 305–312, 1987

    PubMed  CAS  Google Scholar 

  • Anderson JV, Woodruff PWR, Bloom SR. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: a longitudinal study. British Heart Journal 59: 207–211, 1988

    Article  PubMed  CAS  Google Scholar 

  • Awazu M, Imada I, Kon V, Inagami T, Ichikawa I. Role of endogenous atrial natriuretic peptide in congestive heart failure. American Journal of Physiology 257: R641–R646, 1989

    PubMed  CAS  Google Scholar 

  • Bianchi C, Thibault G, Wrobel-Konrad E, De Léan A, Genest J, et al. Atrial natriuretic factor binding sites in experimental congestive heart failure. American Journal of Physiology 257: F515–523, 1989

    PubMed  CAS  Google Scholar 

  • Bidiville J, Waeber G, Porchet M, Nussberger J, Biollaz J, et al. Hemodynamic, renal, and endocrine effects of 4-h infusions of atrial natriuretic peptide in normal volunteers. Fundamental and Clinical Pharmacology 2: 413–429, 1988

    Article  PubMed  CAS  Google Scholar 

  • Biollaz J, Callahan LT, Nussberger J, Waeber B, Gomez HJ, et al. Pharmacokinetics of synthetic atrial natriuretic peptide in normal men. Clinical Pharmacology and Therapeutics 41: 671–677, 1987

    Article  PubMed  CAS  Google Scholar 

  • Bolli P, Müller FB, Linder L, Raine AEG, Resink TJ, et al. The vasodilator potency of atrial natriuretic peptide in man. Circulation 75: 221–228, 1987

    Article  PubMed  CAS  Google Scholar 

  • Breuhaus BA, Saneii HH, Brandt MA, Chimoskey JE. Atriopeptin II lowers cardiac output in conscious sheep. American Journal of Physiology 249: R776–R780, 1985

    PubMed  CAS  Google Scholar 

  • Brenner BM, Ballerman BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiological Reviews 70: 665–698, 1990

    PubMed  CAS  Google Scholar 

  • Brier ME, Harding GB. Pharmacokinetics and pharmacodynamincs of atrial natriuretic peptide after bolus and infusion administration in the isolated perfused rat kidney. Journal of Pharmacology and Experimental Therapeutics 249: 372–377, 1989

    PubMed  CAS  Google Scholar 

  • Bruun NE, Skott P, Giese J. Renal and endocrine effects of physiological variations of atrial natriuretic factor in normal humans. American Journal of Physiology 260: R217–R224, 1991

    PubMed  CAS  Google Scholar 

  • Burrell LM, Lambert HJ, Baylis PH. Effect of atrial natriuretic peptide on thirst and arginine vasopressin release in humans. American Journal of Physiology 260: R475–R479, 1991

    PubMed  CAS  Google Scholar 

  • Casto R, Hilbig J, Schröder G, Stock G. Atrial natriuretic factor inhibits central angiotensin II pressor responses. Hypertension 9: 473–477, 1987

    Article  PubMed  CAS  Google Scholar 

  • Cavero PG, Margulies KB, Winaver J, Seymour AA, Delaney NG, et al. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure. Circulation 82: 196–201, 1990

    Article  PubMed  CAS  Google Scholar 

  • Chang M, Lowe DG, Lewis M, Hellmiss R, Chen E, et al. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases. Nature 341: 68–72, 1989

    Article  PubMed  CAS  Google Scholar 

  • Chiu PR, Tetzloff G, Romano MT, Foster CJ, Sybertz EJ. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. American Journal of Physiology 260: R208–216, 1991

    PubMed  CAS  Google Scholar 

  • Clark BA, Elahi D, Shannon RP, Wei JY, Epstein FH. Influence of age and dose on the end-organ responses to atrial natriuretic peptide in humans. Americal Journal of Hypertension 4: 500–507, 1991

    CAS  Google Scholar 

  • Clinkenbeard C, Sessions C, Shenker Y. The physiological role of atrial natriuretic hormone in the regulation of aldosterone and salt and water metabolism. Journal of Clinical Endocrinology and Metabolism 70: 582–589, 1990

    Article  Google Scholar 

  • Cody RJ, Atlas SA, Laragh JH, Kubo SH, Covit AB, et al. Atrial natriuretic factor in normal subjects and heart failure patients. Journal of Clinical Investigation 78: 1362–1374, 1986

    Article  PubMed  CAS  Google Scholar 

  • Cogan MG. Renal effects of atrial natriuretic factor. Annual Review of Physiology 52: 699–708, 1990

    Article  PubMed  CAS  Google Scholar 

  • Crozier IG, Nicholls MG, Ikram H, Espiner EA, Gomez HJ, et al. Haemodynamic effects of atrial peptide infusion in heart failure. Lancet 1242–1245, 1986

    Google Scholar 

  • Crozier IG, Nicholls MG, Ikram H, Espiner EA, Yandle TG, et al. Atrial natriuretic peptide in humans: production and clearance by various tissues. Hypertension 8 (Suppl. II): 11–15, 1986

    Google Scholar 

  • Cuneo RC, Espiner EA, Nicholls MG, Yandle TG, Livesey JH, et al. Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake. Journal of Clinical Endocrinology and Metabolism 63: 946–953, 1986

    Article  PubMed  CAS  Google Scholar 

  • Cusson JR, du Souich P, Hamet P, Schiffrin EL, Kuchel O, et al. Effects and pharmacokinetics of bolus injections of atrial natriuretic factor in normal volunteers. Journal of Cardiovascular Pharmacology 11: 635–642, 1988

    Article  PubMed  CAS  Google Scholar 

  • Cusson JR, Thibault G, Kuchel O, Hamet P, Cantin M, et al. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension. Journal of Human Hypertension 3: 89–96, 1989

    PubMed  CAS  Google Scholar 

  • Cusson JR, Thibault G, Gutkowska J, Horky K, Hamet P, et al. Prolonged low dose infusion of atrial natriuretic factor in essential hypertension. Journal of Clinical and Experimental Hypertension A 12: 111–135, 1990

    Article  CAS  Google Scholar 

  • Davis CL, Briggs JP. Effect of reduction in renal artery pressure on atrial natriuretic peptide-induced natriuresis. American Journal of Physiology 252: F146–F153, 1987

    PubMed  CAS  Google Scholar 

  • Debinski W, Kuchel O, Buu NT. Atrial natriuretic factor is a new neuromodulatory peptide. Neuroscience 36: 15–20, 1990

    Article  PubMed  CAS  Google Scholar 

  • DeBold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sciences 28: 89–94, 1981

    Article  CAS  Google Scholar 

  • Ebert TJ, Skelton MM, Cowley AW. Dynamic cardiovascular responses to infusions of atrial natriuretic factor in humans. Hypertension 11: 537–544, 1988

    Article  PubMed  CAS  Google Scholar 

  • Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor. Circulation Research 62: 191–195, 1988

    Article  PubMed  CAS  Google Scholar 

  • Eiskjaer H, Bagger JP, Danielsen H, Jensen JD, Jespersen B, et al. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man. International Journal of Cardiology 33: 61–74, 1991

    Article  PubMed  CAS  Google Scholar 

  • Epstein M, Loutzenhiser R, Friedland E, Aceto RM, Camargo MJF, et al. Relationship of increased plasma atrial natriuretic factor and renal sodium handling during immersion-induced central hypervolemia in normal humans. Journal of Clinical Investigation 79: 738–745, 1987

    Article  PubMed  CAS  Google Scholar 

  • Fiscus RR, Rapoport RM, Waldman SA, Murad F. Atriopeptin II elevates cyclic GMP, activates cyclic GMP-dependent protein kinase and causes relaxation in rat thoracic aorta. Biochimica et Biophysica Acta 846: 179–184, 1985

    Article  PubMed  CAS  Google Scholar 

  • Gaillard CA, Koomans HA, Dorhout Mees EJ. Enalapril attenuates natriuresis of atrial natriuretic factor in humans. Hypertension 11: 160–165, 1988

    Article  PubMed  CAS  Google Scholar 

  • Gardner DG, Vlasuk GP, Baxter JD, Fiddes JC, Lewicki JA. Identification of atrial natriuretic factor gene transscripts in the central nervous system of the rat. Proceedings of the National Academy of Science of the United States of America 84: 2175–2179, 1987

    Article  CAS  Google Scholar 

  • Gardner DG, Newman ED, Nakamura KK, Nguyen KPT. Endothelin increases the synthesis and secretion of atrial natriuretic peptide in neonatal rat cardiocytes. American Journal of Physiology 261: E177–E182, 1991

    PubMed  CAS  Google Scholar 

  • Gasic S, Vierhapper H, Nowotny P, Heinz G, Waldhäusl W. Contribution of leg vascular tissues to the overall metabolic clearance of human atrial natriuretic factor (hANF) in man. International Journal of Clinical Pharmacology, Therapeutics and Toxicology 29: 113–115, 1991

    CAS  Google Scholar 

  • Gerbes AL, Vollmar AM. Degradation and clearance of atrial natriuretic factors (ANF). Life Sciences 47: 1173–80, 1990

    Article  PubMed  CAS  Google Scholar 

  • Gillies AH, Crozier IG, Nicholls MG, Espiner EA, Yandle TG. Effect of posture on clearance of atrial natriuretic peptide from plasma. Journal of Clinical Endocrinology and Metabolism 65: 1095–1097, 1987

    Article  PubMed  CAS  Google Scholar 

  • Gnädinger MP, Lang RE, Hasler L, Uehlinger DE, Shaw S, et al. Plasma kinetics of synthetic alpha-human atrial natriuretic peptide in man. Mineral and Electrolyte Metabolism 12: 371–374, 1986

    PubMed  Google Scholar 

  • Goetz KL. Renal natriuretic peptide (urodilatin?) and atriopeptin: evolving concepts. American Journal of Physiology 261: F921–F932, 1991

    PubMed  CAS  Google Scholar 

  • Goy JJ, Waeber J, Bidiville J, Biollaz J, Nicod P, et al. Infusion of atrial natriuretic peptide to patients with congestive heart failure. Journal of Cardiovascular Pharmacology 12: 562–570, 1988

    Article  PubMed  CAS  Google Scholar 

  • Grandis DJ, Uretsky BF, Ray SM, Vassilaros L, Verbalis JG, et al. Differential effects of atrial natriuretic peptide infusion at physiological doses in different postures in humans. American Journal of Hypertension 4: 219–227, 1991

    PubMed  CAS  Google Scholar 

  • Gros C, Noël N, Souque A, Schwartz JC, Danvy D, et al. Mixed inhibitors of angiotensin-converting enzyme (EC 3.4.15.1) and enkephalinase (EC 3.4.24.11): rational design, properties, and potential cardiovascular applications of glycopril and alatriopril. Proceedings of the National Academy of Science of the United States of America 88: 4210–4214, 1991

    Article  CAS  Google Scholar 

  • Hamet P, Tremblay J, Pang SC, Skuherska R, Schiffrin EL, et al. Cyclic GMP as mediator and biological marker of atrial natriuretic factor. Journal of Hypertension 4 (Suppl. 2): S49–S56, 1986

    PubMed  CAS  Google Scholar 

  • Heim JM, Gottmann K, Weil J, Haufe MC, Gerzer R. Is cyclic GMP a clinically useful marker for ANF action? Zeitschrift fur Kardiologie 77 (Suppl. 2): 41–46, 1988

    PubMed  CAS  Google Scholar 

  • Heisler S, Morrier E. Bovine adrenal medullary cells contain functional atrial natriuretic peptide receptors. Biochemical and Biophysical Research Communications 150: 781–787, 1988

    Article  PubMed  CAS  Google Scholar 

  • Hensen J, Abraham, WT, Lesnefsky EJ, Levensen B, Groves BM, et al. Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction. Kidney International 42: 1333–1339, 1992

    Article  Google Scholar 

  • Higuchi K, Nwata H, Kato K, Ibayashi H, Matsuo H. α-Human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells. Journal of Clinical Endocrinology and Metabolism 62: 941–944, 1986

    Article  PubMed  CAS  Google Scholar 

  • Hirata Y, Ishii M, Matsuoka H, Sugimoto T, Iizuka M, et al. Plasma concentrations of α-human atrial natriuretic polypeptide and cyclic GMP in patients with heart disease. American Heart Journal 113: 1463–1469, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hirooka Y, Takeshita A, Imaizumi T, Suzuki S, Yoshida M, et al. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patiens with heart failure. Circulation 82: 147–153, 1990

    Article  PubMed  CAS  Google Scholar 

  • Hirth C, Stasch JP, Kazda S, John A, Morich F, et al. Blockade of the response to volume expansion by monoclonal antibodies against atrial natriuretic peptides. Klinische Wochenschrift 65 (Suppl. VIII): 87–91, 1987

    PubMed  CAS  Google Scholar 

  • Hollister AS, Rodeheffer RJ, White FR, Potts JR, Imada T, et al. Clearance of atrial natriuretic factor by lung, liver and kidney in human subjects and the dog. Journal of Clinical Investigation 83: 623–628, 1989

    Article  PubMed  CAS  Google Scholar 

  • Hollister AS, Tanaka I, Imada T, Onrot T, Biaggoni J, et al. Sodium loading and posture modulate human atrial natriuretic factor plasma levels. Hypertension 8 (Suppl. II): II106–II111, 1986

    PubMed  CAS  Google Scholar 

  • Hughes A, Thom S, Goldberg P, Martin G, Sever P. Direct effect of α-human atrial natriuretic peptide on human vasculature in vivo and in vitro. Clinical Science 74: 207–211, 1988

    PubMed  CAS  Google Scholar 

  • Huxley VH, Tucker VL, Verburg KM, Freeman RH. Increased capillary hydraulic conductivity induced by atrial natriuretic peptide. Circulation Research 60: 304–307, 1987

    Article  PubMed  CAS  Google Scholar 

  • Itoh H, Nakao K, Sugawara A, Saito Y, Mukoyama M, et al. τ-atrial natriuretic polypeptide (τANP)-derived peptides in human plasma: cosecretion of N-terminal τANP fragment and αANP. Journal of Clinical Endocrinology and Metabolism 67: 429–437, 1988

    Article  PubMed  CAS  Google Scholar 

  • Itoh H, Pratt RE, Dzau VJ. Interaction of atrial natriuretic polypeptide and angiotensin II on proto-oncogene expression and vascular cell growth. Biochemical and Biophysical Research Communications 176: 1601–1609, 1991

    Article  PubMed  CAS  Google Scholar 

  • Jansen TLThA, Smits P, Tan ACITL, Thien Th. Attenuated forearm vasodilator response to atrial natriuretic factor in the elderly. Hypertension 18: 640–647, 1991

    Article  PubMed  CAS  Google Scholar 

  • Janssen WMT, de Zeeuw D, van der Hem GH, de Jong PE. Antihypertensive effect of a 5-day infusion of atrial natriuretic factor in humans. Hypertension 13: 640–646, 1989

    Article  PubMed  CAS  Google Scholar 

  • Jardine AG, Connell JM, Northridge D, Dilly SG, Cussans NJ, et al. The atriopeptidase inhibitor 69,578 increases atrial natriuretic factor and causes a natriuresis in normal humans. American Journal of Hypertension 3: 661–667, 1990

    PubMed  CAS  Google Scholar 

  • Kahn JC, Patey M, Dubois-Rande JL, Merlet P, Castaigne A, et al. Effect of sinorphan on plasma atrial natriuretic factor in congestive heart failure. Lancet 335: 118–119, 1990

    Article  PubMed  CAS  Google Scholar 

  • Koepke JP, Tyler LD, Trapani AJ, Bovy PR, Spear KL, et al. Interaction of non-guanylate cyclase-linked atriopeptin receptor ligand and endopeptidase inhibition in conscious rats. Journal of Pharmacology and Experimental Therapeutics 249: 172–176, 1989

    PubMed  CAS  Google Scholar 

  • Kohno M, Yasunari K, Yokokawa K, Murakawa K, Horio T, et al. Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells. Journal of Clinical Investigation 87: 1999–2004, 1991

    Article  PubMed  CAS  Google Scholar 

  • Kohno M, Yokokawa K, Yasunari K, Murakawa K, Kurihara N, et al. Acute effects of α- and β-adrenoceptor blockade on plasma atrial natriuretic peptides during exercise in elderly patients with mild hypertension. Chest 99: 847–854, 1991

    Article  PubMed  CAS  Google Scholar 

  • Kollenda MC, Vollmar AM, McEnroe GA, Gerbes AL. Dehydration increases the density of C receptors for AN F on rat glomerular membranes. American Journal of Physiology 258: R1084–R1088, 1990

    PubMed  CAS  Google Scholar 

  • Koller KJ, Lowe DG, Bennett GL, Minamino N, Kangawa K, et al. Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252: 120–123, 1991

    Article  PubMed  CAS  Google Scholar 

  • Komatsu Y, Nakao K, Suga S, Ogawa Y, Mukoyama M, et al. C-type natriuretic peptide (CNP) in rats and humans. Endocrinology 129: 1104–1106, 1991

    Article  PubMed  CAS  Google Scholar 

  • Kosoglou T, Herron JM, Chen R, Given B, Sybertz EJ, et al. Antihypertensive effect of the atriopeptidase inhibitor SCH 34,826 in essential hypertension. Circulation 82 (Suppl. III): abstract 2201, 1990

    Google Scholar 

  • Kromer EP, Eisner D, Kahles HW, Riegger GAJ. Effects of atrio-peptidase inhibitor UK 79,300 on left ventricular hydraulic load in patients with congestive heart failure. American Journal of Hypertension 4: 460–463, 1991

    PubMed  CAS  Google Scholar 

  • Kuchel O, Debinski W, Racz K, Buu NT, Garcia R, et al. An emerging relationship between peripheral sympathetic nervous activity and atrial natriuretic factor. Life Sciences 40: 1545–1551, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kurtz A, Delia Bruna R, Pfeilschifter J, Taugner R, Bauer C. Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP-mediated process. Proceedings of the National Academy of Science of the United States of America 83: 4769–4773, 1986

    Article  CAS  Google Scholar 

  • Lang CC, Motwani J, Coutie WJ, Struthers AD. Influence of can-doxatril on plasma brain natriuretic peptide in heart failure. Lancet 338: 255, 1991

    Article  PubMed  CAS  Google Scholar 

  • Lang RE, Thölken H, Ganten D, Luft FC, Ruskoaho H, et al. Atrial natriuretic factor-a circulating hormone stimulated by volume loading. Nature 314: 264–266, 1985

    Article  PubMed  CAS  Google Scholar 

  • Lappe RW, Todt JA, Wendt RL. Hemodynamic effects of infusion versus bolus administration of atrial natriuretic factor. Hypertension 8: 866–873, 1986

    Article  PubMed  CAS  Google Scholar 

  • Lee ME, Miller WL, Edwards BS, Burnett JC. Role of endogenous atrial natriuretic factor in acute congestive heart failure. Journal of Clinical Investigation 84: 1962–1966, 1989

    Article  PubMed  CAS  Google Scholar 

  • LeFrancois P, Clerc G, Duchier J, Lim C, Lecomte JM, et al. Antihypertensive activity of sinorphan. Lancet 336: 307–308, 1990

    Article  PubMed  CAS  Google Scholar 

  • Levin ER, Frank HJL, Chaudhari A, Kirschenbaum MA, Bandt A, et al. Decreased atrial natriuretic factor receptors and imparied cGMP generation in glomeruli from the cardiomyopathic hamster. Biochemical and Biophysical Research Communications 159: 807–814, 1989

    Article  PubMed  CAS  Google Scholar 

  • Luft FC, Lang RE, Aronoff GR, Ruskoaho H, Toth M. Atriopeptin III kinetics and pharmacodynamics in normal and anephric rats. Journal of Pharmacology and Experimental Therapeutics 236: 416–418, 1986

    PubMed  CAS  Google Scholar 

  • Maack T, Suzuki M, Almeida FA, Nussenzweig D, Scarborough RM, et al. Physiological role of silent receptors of atrial natriuretic factor. Science 238: 675–678, 1987

    Article  PubMed  CAS  Google Scholar 

  • Mann E, Lang RE, Leidig M, Ritz E. Effect of angiotensin I converting enzyme inhibition on circulating atrial natriuretic peptide in humans. Klinische Wochenschrift 64 (Suppl. VI): 13–15, 1986

    PubMed  CAS  Google Scholar 

  • Marleau S, Ong H, de Léan A, du Souich P. Disposition and dynamics of atrial natriuretic factor in conscious rabbits. Journal of Pharmacology and Experimental Therapeutics 251: 328–333, 1989

    PubMed  CAS  Google Scholar 

  • Marumo F, Sakamoto H, Ando K, Ishigami T, Kawakami M. A highly sensitive radioimmunoassay of atrial natriuretic peptide (ANP) in human plasma and urine. Biochemical and Biophysical Research Communications 137: 231–236, 1986

    Article  PubMed  CAS  Google Scholar 

  • Marumo F, Kurosawa T, Takeda S, Katoh Y, Hasegawa H, et al. Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failure. Klinische Wochenschrift 66: 675–681, 1988

    Article  PubMed  CAS  Google Scholar 

  • Matsuoka H, Ishii M, Hirata Y, Atarashi K, Sugimoto T, et al. Evidence for lack of a role of cGMP in the effect of α-hANP on aldosterone inhibition. American Journal of Physiology 252: E643–E647, 1987

    PubMed  CAS  Google Scholar 

  • McGregor A, Richards M, Espiner E, Yandle T, Ikram H. Brain natriuretic peptide to man: actions and metabolism. Journal of Clinical Endocrinology and Metabolism 70: 1103–1107, 1990

    Article  PubMed  CAS  Google Scholar 

  • Meleagros L, Gibbs JSR, Ghatei MA, Bloom SR. Increase in plasma concentrations of cardiodilatin (amino terminal pro-atrial natriuretic peptide) in cardiac failure and during recumbency. British Heart Journal 60: 39–44, 1988

    Article  PubMed  CAS  Google Scholar 

  • Miyamori I, Ikeda M, Matsubara T, Okamoto S, Koshida H, et al. The renal, cardiovascular and hormonal actions of human atrial natriuretic peptide in man: effects of indomethacin. British Journal of Clinical Pharmacology 23: 425–431, 1987

    Article  PubMed  CAS  Google Scholar 

  • Moe GW, Canepa-Anson R, Armstrong PW. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in rleation to biologic effects in severe heart failure. Journal of Cardiovascular Pharmacology 19: 691–700, 1992

    PubMed  CAS  Google Scholar 

  • Molina CR, Fowler MB, McCrory S, Peterson S, Myers BO, et al. Hemodynamic, renal and endocrine effects of atrial natriuretic peptide infusion in severe heart failure. Journal of the American College of Cardiology 12: 175–186, 1988

    Article  PubMed  CAS  Google Scholar 

  • Morice A, Pepke-Zaba J, Loysen E, Lapworth R, Ashby M, et al. Low dose infusion of atrial natriuretic peptide causes salt and water excretion in norman man. Clinical Science 74: 359–363, 1988

    PubMed  CAS  Google Scholar 

  • Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, et al. Brain natriuretic hormone as a novel cardiac hormone in humans. Journal of Clinical Investigation 87: 1402–1412, 1991

    Article  PubMed  CAS  Google Scholar 

  • Münzel T, Drexler H, Holtz J, Kurtz S, Just H. Mechanisms involved in the response to prolonged infusion of atrial natriuretic factor in patients with chronic heart failure. Circulation 83: 191–201, 1991

    Article  PubMed  Google Scholar 

  • Nakao K, Sugawara A, Morii N, Sakamoto M, Yamada T, et al. The pharmacokinetics of α-human atrial natriuretic polypeptide in healthy subjects. European Journal of Clinical Pharmacology 31: 101–103, 1986

    Article  PubMed  CAS  Google Scholar 

  • Northridge DB, Jardine AG, Findlay IN, Archibald M, Dilly SG, et al. Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure. American Journal of Hypertension 3: 682–687, 1990

    PubMed  CAS  Google Scholar 

  • Nussenzweig DR, Lewicki JA, Maack T. Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor. Journal of Biological Chemistry 265: 20952–20958, 1990

    Google Scholar 

  • O’Connell JE, Jardine AG, Davidson G, Connell JMC. Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension. Journal of Hypertension 10: 271–277, 1992

    Article  PubMed  Google Scholar 

  • Oelkers W, Kleiner S, Bähr V. Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans. Hypertension 12: 462–467, 1988

    Article  PubMed  CAS  Google Scholar 

  • Ohashi M, Fujio N, Nawata H, Kato KI, Matsuo H, et al. Pharmacokinetics of synthetic α-human atrial natriuretic polypeptide in normal men: effect of aging. Regulatory Peptides 19: 265–272, 1987

    Article  PubMed  CAS  Google Scholar 

  • Olins GM, Spear KL, Siegel NR, Zurcher-Neely HA. Inactivation of atrial natriuretic factor by the renal brush border. Biochimica et Biophysica Acta 901: 97–100, 1987

    Article  PubMed  CAS  Google Scholar 

  • Opgenorth TJ, Burnett JC, Granger JP, Scriven TA. Effects of atrial natriuretic peptide on renin secretion in nonfiltering kidney. American Journal of Physiology 250: F798–F801, 1986

    PubMed  CAS  Google Scholar 

  • Pandey KN, Osteen KG, Inagami T. Specific receptor-mediated stimulation of progesterone secretion and cGMP accumulation by rat atrial natriuretic factor in cultured human granulosa-lutein (G-L) cells. Endocrinology 121: 1195–1197, 1987

    Article  PubMed  CAS  Google Scholar 

  • Parkes DG, Coghlan JP, Lewicki JA, Scarborough RM, Scoggins BA. Hemodynamic effects of atrial natriuretic factor clearance receptor occupancy in conscious sheep. American Journal of Hypertension 3: 829–832, 1990

    PubMed  CAS  Google Scholar 

  • Poole S, Gaines Das RE, Dzau VJ, Richard AM, Robertson JIS. The international standard for atrial natriuretic factor-calibration by an international collaborative study. Hypertension 12: 629–634, 1988

    Article  PubMed  CAS  Google Scholar 

  • Porter JG, Wang Y, Schwartz K, Arfsten A, Loffredo A, et al. Characterization of the atrial natriuretic peptide clearance receptor using a vaccinia virus expression receptor. Journal of Biological Chemistry 263: 18827–18833, 1988

    PubMed  CAS  Google Scholar 

  • Raine AEG, Erne P, Bürgisser E, Müller FB, Bolli P, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. New England Journal of Medicine 315: 533–537, 1986

    Article  PubMed  CAS  Google Scholar 

  • Redfield MM, Edwards BS, Heublein DM, Burnett JC. Restoration of renal response to atrial natriuretic factor in experimental low output heart failure. American Journal of Physiology 257: R917–R923, 1989

    PubMed  CAS  Google Scholar 

  • Richards AM, Nicholls MG, Espiner EA, Ikram H, Yandle TG, et al. Effects of α-human atrial natriuretic peptide in essential hypertension. Hypertension 7: 812–817, 1985

    Article  PubMed  CAS  Google Scholar 

  • Richards AM, Tonolo G, McIntyre GD, Leckie BJ, Robertson JIS. Radio-immunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extracted methods. Journal of Hypertension 5: 227–236, 1987

    Article  PubMed  CAS  Google Scholar 

  • Richards AM, Espiner EA, Ikram H, Yandle TG. Atrial natriuretic factor in hypertension: bioactivity at normal plasma levels. Hypertension 14: 261–268, 1989

    Article  PubMed  CAS  Google Scholar 

  • Richards M, Espiner E, Frampton C, Ikram H, Yandle T, et al. Inhibition of endopeptidase EC 24.11 in humans: renal and endocrine effects. Hypertension 16: 269–276, 1990

    Article  PubMed  CAS  Google Scholar 

  • Richards AM, Wittert G, Espiner EA, Yandle TG, Frampton C, et al. EC 24.11 inhibition in man alters clearance of atrial natriuretic peptide. Journal of Clinical Endocrinology and Metabolism 72: 1317–1322, 1991

    Article  PubMed  CAS  Google Scholar 

  • Ronco P, Pollard H, Galceran M, Delauche M, Schwartz JC, et al. Distribution of enkephalinase (membrane metalloendopeptidase EC 3.4.24.11) in rat organs: detection using a monoclonal antibody. Laboratory Investigation 58: 210–217, 1988

    PubMed  CAS  Google Scholar 

  • Rutlen DL, Christensen G, Helgesen KG, Ilebekk A. Influence of atrial natriuretic factor on intravascular volume displacement in pigs. American Journal of Physiology 259: H1595–H1600, 1990

    PubMed  CAS  Google Scholar 

  • Saito Y, Nakao K, Nishimura K, Sugawara A, Okumura K, et al. Clinical application of atrial natriuretic peptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 76: 115–124, 1987

    Article  PubMed  CAS  Google Scholar 

  • Sakurai H, Naruse M, Naruse K, Obana K, Higashida T, et al. Postural suppression of plasma atrial natriuretic polypeptide concentrations in man. Clinical Endocrinology 26: 173–178, 1987

    Article  PubMed  CAS  Google Scholar 

  • Sasaki A, Kida O, Kato J, Nakamura S, Kodama K, et al. Effects of antiserum against α-rat atrial natriuretic peptide in anesthetized rats. Hypertension 10: 308–312, 1987

    Article  PubMed  CAS  Google Scholar 

  • Saxenhofer H, Raselli A, Weidmann P, Forssmann WG, Bub A, et al. Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. American Journal of Physiology 259: F832–8, 1990

    PubMed  CAS  Google Scholar 

  • Schiffrin EL. Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure. Clinical Science 74: 213–218, 1988

    PubMed  CAS  Google Scholar 

  • Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, et al. Isolation and structural analysis of ‘urodilatin’, a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klinische Wochenschrift 66: 752–759, 1988

    Article  PubMed  CAS  Google Scholar 

  • Schwartz JC, Gros C, Lecomte JM, Bralet J. Enkephalinase (EC 3.4.24.11) inhibitors: protection of endogenous ANF against inactivation and potential therapeutic applications. Life Sciences 47: 1279–1297, 1990

    Article  PubMed  CAS  Google Scholar 

  • Seino M, Abe K, Nushiro N, Yoshinaga K. Nifedipine enhances the vasodepressor and natriuretic effects of atrial natriuretic peptide. Hypertension 11: 34–40, 1988

    Article  PubMed  CAS  Google Scholar 

  • Shenker Y. Atrial natriuretic hormone effect on renal function and aldosterone secretion in sodium depletion. American Journal of Physiology 255: R867–R873, 1988

    PubMed  CAS  Google Scholar 

  • Shima J, Ogihara T, Hara H, Iinuma K, Kumahara Y. Effects of calcium antagonists on the secretion of atrial natriuretic peptide in normal volunteers. Current Therapeutic Research 42: 115–123, 1987

    Google Scholar 

  • Singer DR, Markandu ND, Buckley MG, Miller MA, Sagnella GA, et al. Dietary sodium and inhibition of neutral endopeptidase 24.11 in essential hypertension. Hypertension 18: 798–804, 1991

    Article  PubMed  CAS  Google Scholar 

  • Sole J, Bauer K, Timnik A, Solcova A, Döhlemann C, et al. Combination of high-performance liquid chromatography and radioimmunoassay for the measurement of urodilatin and α-hANP in the urine of healthy males. Life Sciences 48: 2451–2456, 1991

    Article  Google Scholar 

  • Solomon LR, Atherton JC, Bobinski H, Green R. Effect of dietary sodium chloride and posture on plasma immunoreactive atrial natriuretic peptide concentrations in man. Clinical Science 72: 201–208, 1987

    PubMed  CAS  Google Scholar 

  • Solomon RL, Atherton JC, Bobinski H, Hillier V, Green R. Effect of low dose infusion of atrial natriuretic peptide on renal function in man. Clinical Science 75: 403–410, 1988

    PubMed  CAS  Google Scholar 

  • Sosa RE, Volpe M, Marion DN, Atlas SA, Laragh HE, et al. Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. American Journal of Physiology 250: F520–F524, 1986

    PubMed  CAS  Google Scholar 

  • Stasch JP, Hirth-Dietrich C, Kazda S, Neuser D. Role of endogenous ANP on endocrine function investigated with a monoclonal antibody. Peptides 11: 577–582, 1990

    Article  PubMed  CAS  Google Scholar 

  • Stephenson SL, Kenny AJ. The hydrolysis of α-human atrial natriuretic peptide by pig kidney microvillar membranes is initiated by endopeptidase-24.11. Biochemical Journal 243: 183–187, 1987

    PubMed  CAS  Google Scholar 

  • Strom TM, Weil J, Braun F, Stangl K, Timnik A, et al. Binding sites for atrial natriuretic peptide on platelets in patients with congestive heart failure. European Journal of Clinical Investigation 18: 524–528, 1988

    Article  PubMed  CAS  Google Scholar 

  • Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 332: 78–81, 1988

    Article  PubMed  CAS  Google Scholar 

  • Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochemical and Biophysical Research Communications 168: 863–870, 1990

    Article  PubMed  CAS  Google Scholar 

  • Sugawara A, Nakao K, Morii N, Sakamoto M, Suda M, et al. α-human atrial natriuretic polypeptide is released from the heart and circulates in the body. Biochemical and Biophysical Research Communications 129: 439–446, 1985

    Article  PubMed  CAS  Google Scholar 

  • Sybertz EJ, Chiu PJS, Vemulapali S, Watkins R, Haslanger MF. Atrial natriuretic factor — potentiating and antihypertensive activity of SCH 34826: an orally active neutral metalloendopeptidase inhibitor. Hypertension 15: 152–161, 1990

    Article  PubMed  CAS  Google Scholar 

  • Tan ACITL, Rosmalen FMA, Hofman JA, Kloppenborg PWC, Benraad ThJ. Evaluation of a direct assay for atrial natriuretic peptide. Clinica Chimica Acta 179: 1–12, 1989

    Article  CAS  Google Scholar 

  • Tan ACITL, Hoefnagels WHL, Swinkels LMJW, Kloppenborg PWC, Benraad THJ. The effect of volume expansion on atrial natriuretic peptide and cyclic guanosine monophosphate levels in young and aged subjects. American Journal of the Geriatric Society 38: 1215–1219, 1990

    CAS  Google Scholar 

  • Tan ACITL, Jansen TLThA, Thien Th, Russel FGM, Termond EFS, et al. Kinetics of atrial natriuretic peptide in young and elderly subjects. European Journal of Clinical Pharmacology 42: 449–452, 1992

    PubMed  CAS  Google Scholar 

  • Thamsborg G, Sykulski R, Larsen J, Storm T, Keller N. Effect of β 1-adrenoceptor blockad on plasma levels of atrial natriuretic peptide during exercise in normal man. Clinical Physiology 7: 313–318, 1987

    Article  PubMed  CAS  Google Scholar 

  • Tonolo G, Richards AM, Namunta P, Troffa C, Pazzola A, et al. Low-dose infusion of atrial natriuretic factor in mild essential hypertension. Circulation 80: 893–902, 1989

    Article  PubMed  CAS  Google Scholar 

  • Tremblay J, Gerzer R, Vinay P, Pang SC, Beliveau R, et al. The increase of cGMP by atrial natriuretic factor correlates with the distribution of particulate guanylate cyclase. FEBS Letter 181: 17–22, 1985

    Article  CAS  Google Scholar 

  • Trippodo NC, Cole FE, Fröhlich ED, MacPhee AA. Atrial natriuretic peptide decreases circulatory capacitance in areflexic rats. Circulation Research 59: 291–296, 1986

    Article  PubMed  CAS  Google Scholar 

  • Tsai RC, Yamaji T, Ishibashi M, Takaku F, Pang SC, et al. Atrial natriuretic peptide during supraventricular tachycardia and relation to hemodynamic changes and renal function. American Journal of Cardiology 61: 1260–1264, 1988

    Article  PubMed  CAS  Google Scholar 

  • Tsunoda K, Mendelsohn FAD, Sexton PM, Chai SY, Hodsman GP, et al. Decreased atrial natriuretic peptide binding in renal medulla in rats with chronic heart failure. Circulation Research 62: 155–161, 1988

    Article  PubMed  CAS  Google Scholar 

  • Uehlinger DE, Zaman T, Weidmann P, Shaw S, Gnädinger MP. Pressure dependence of atrial natriuretic peptide during norepinephrine infusion in humans. Hypertension 10: 249–253, 1987

    Article  PubMed  CAS  Google Scholar 

  • Valentin JP, Qiu C, Weidemann E, Gardner D, Hunphreys MH. Inhibition of neutral endopeptidases amplifies the effects of endogenous atrial natriuretic peptide on blood pressure and fluid partition. American Journal of Hypertension 5: 88–91, 1992

    PubMed  CAS  Google Scholar 

  • Veress AT, Sonnenberg H. Right atrial appendectomy reduces the renal response to acute hypervolemia in the rat. American Journal of Physiology 247: R610–R613, 1984

    PubMed  CAS  Google Scholar 

  • Vierhapper H, Gasic S, Nowotny P, Waldäusl W. Splanchnic disposal of human atrial natriuretic peptide in humans. Metabolism 37: 973–975, 1988

    Article  PubMed  CAS  Google Scholar 

  • Vierhapper H, Gasic S, Nowotny P, Waldhäusl W. Renal disposal of human atrial natriuretic peptide in man. Metabolism 39: 341–342, 1990

    Article  PubMed  CAS  Google Scholar 

  • Vollmar AM, Mytaka C, Arendt RM, Schulz R. Atrial natriuretic peptide in bovine corpus luteum. Endocrinology 123: 762–767, 1988

    Article  PubMed  CAS  Google Scholar 

  • Vollmar AM. Atrial natriuretic peptide in peripheral organs other than the heart. Klinische Wochenschrift 68: 699–708, 1990

    Article  PubMed  CAS  Google Scholar 

  • Volpe M, Mle AF, Indolfi C, DeLuca N, Lembo G, et al. Hemodynamic and hormonal effects of atrial natriuretic factor in patients with essential hypertension. American Journal of the College of Cardiology 10: 787–793, 1987

    Article  CAS  Google Scholar 

  • Vorderwinkler KP, Artner-Dworzak E, Jakob G, Mair J, Dienstl F, et al. Release of cyclic guanosine monophosphate evaluated as a diagnostic tool in cardiac diseases. Clinical Chemistry 37: 186–190, 1991

    PubMed  CAS  Google Scholar 

  • Waldman SA, Rapoport RM, Murad F. Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissue. Journal of Biological Chemistry 259: 14332–14334, 1984

    PubMed  CAS  Google Scholar 

  • Wambach G, Schittenheim U, Bonner G, Kaufmann W. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I — converting-enzyme inhibition. Cardiology 76: 418–427, 1989

    Article  PubMed  CAS  Google Scholar 

  • Wei Y, Holmberg SW, Leahy KM, Olins PD, Devine CS, et al. Heparin interferes with the biological effectiveness of atriopeptin. Hypertension 9: 607–610, 1987

    Article  PubMed  CAS  Google Scholar 

  • Weidmann P, Gnädinger MP, Ziswiler HR, Shaw S, Bachmann C, et al. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. Journal of Hypertension 4: S71–S83, 1986a

    Article  PubMed  CAS  Google Scholar 

  • Weidmann P, Hasler L, Gnädinger MP, Lang RE, Uehlinger DE, et al. Blood levels and renal effects of atrial natriuretic peptide in normal man. Journal of Clinical Investigation 77: 734–742, 1986b

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson GR. Clearance approaches in pharmacology. Pharmacology Reviews 39: 1–47, 1987

    CAS  Google Scholar 

  • Williams TDM, Walsh KP, Lightman SL, Sutton R. Atrial natriuretic peptide inhibits postural release of renin and vasopressin in humans. American Journal of Physiology 255: R368–R372, 1988

    PubMed  CAS  Google Scholar 

  • Widimsky J, Debinski W, Kuchel P, Buu NT, Du Souich P. Effect of prolonged high salt intake on atrial natriuretic factor’s kinetics in rats. Peptides 11: 501–506, 1990

    Article  PubMed  CAS  Google Scholar 

  • Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, et al. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and hemodialysis. Clinical Science 71: 157–160, 1986

    PubMed  CAS  Google Scholar 

  • Winquist RJ, Faisan EP, Nutt RP. Vasodilator profile of synthetic atrial natriuretic factor. European Journal of Pharmacology 102: 169–173, 1984

    Article  PubMed  CAS  Google Scholar 

  • Winquist RJ. Possible mechanism underlying the vasorelaxant response to atrial natriuretic factor. Federation Proceedings 45: 2371–2375, 1986

    PubMed  CAS  Google Scholar 

  • Wong NLM, Wong EFC, Au GH, Hu DCK. Effect of α- and β-adrenergis stimulation on atrial natriuretic peptide release in vitro. American Journal of Physiology 255: E260–E264, 1988

    PubMed  CAS  Google Scholar 

  • Woolf AS, Lyon TL, Hoffbrand BI, Cohen SL, Moult PJA. Effects of physiological infusion of atrial natriuretic factor on healthy subjects and patients with the nephrotic syndrome. Nephron 52: 244–250, 1989

    Article  PubMed  CAS  Google Scholar 

  • Yandle TG, Richards AM, Nicholls MG, Cuneo R, Espiner EA, et al. Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. Life Sciences 38: 1827–1833, 1986

    Article  PubMed  CAS  Google Scholar 

  • Yates NA, Coghlan JP, Murphy GJ, Scoggins BA, McDougall JG. Renal actions of atrial natriuretic factor: modulation of effect by changes in sodium status and aldosterone. American Journal of Physiology 258: F684–649, 1990

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Experimental and Chemical Endocrinology, Department of Pharmacology, and Division of General Internal Medicine, Department of Medicine, University Hospital of Nijmegen, Nijmegen, The Netherlands

    Adriaan C. I. T. L. Tan, Frans G. M. Russel, Theo Thien & Theo J. Benraad

Authors
  1. Adriaan C. I. T. L. Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frans G. M. Russel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Theo Thien
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Theo J. Benraad
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, A.C.I.T.L., Russel, F.G.M., Thien, T. et al. Atrial Natriuretic Peptide. Clin-Pharmacokinet 24, 28–45 (1993). https://doi.org/10.2165/00003088-199324010-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199324010-00003

Keywords

Search

Navigation